Diplomat Pharmacy (DPLO) Receives Price Target

Diplomat Pharmacy (DPLO) : The highest short term price target forecast on Diplomat Pharmacy (DPLO) is $42 and the lowest target price is $33. A total of 10 equity analysts are currently covering the company. The average price of all the analysts is $38 with a standard deviation of $2.71.

Diplomat Pharmacy (DPLO) : 12 analysts are covering Diplomat Pharmacy (DPLO) and their average rating on the stock is 1.92, which is read as a Buy. 6 equity analysts believe that the stock has a bright future and the price doesnt capture all of its upside, hence they rate the stock as a Strong Buy. Diplomat Pharmacy (DPLO) also receives 1 more Buy recommendations from analysts who believe that the stock will do well going forward. A Zacks Investment Research rank of 3, which recommends a Hold affirms that they expect a large upside in the stock from the current levels. A total of 5 brokerage firms believe that the stock is fairly valued, hence they advise a Hold on the stock.


Also, Cowen & Company initiates coverage on Diplomat Pharmacy (NYSE:DPLO). Cowen & Company has a Market Perform rating on the shares. The rating by the firm was issued on June 24, 2016.

Diplomat Pharmacy (NYSE:DPLO): During Thursdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $31.28 and $31.02 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $31.61. The buying momentum continued till the end and the stock did not give up its gains. It closed at $31.38, notching a gain of 0.29% for the day. The total traded volume was 355,723 . The stock had closed at $31.29 on the previous day.

Diplomat Pharmacy, Inc. (Diplomat) is an independent specialty pharmacy in the United States. The Company provides specialty pharmacy support services to a national network of retailers and independent pharmacy groups, hospitals and health systems. The Company offers services in Specialty Drug Dispensing, which includes its specialty infusion pharmacy services. The specialty drug dispensing services include Patient Care Coordination, Clinical Services, Compliance and Persistency Programs, Patient Financial Assistance, Specialty Pharmacy Training/Consulting (Diplomat University), Benefits Investigation, Prior Authorization, Risk Evaluation and Medication Strategy (REMS), Retail Specialty Services, Hospital and Health System Services and Hub Services. The Company help patients adhere to complicated medication therapies, process refills and manage any side effects and insurance concerns to ensure they get the standard of care.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.